We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.9B
1-Year Est. Return 23.65%
This Fund
S&P 500
This Quarter Est. Return
+2.21%
1 Year Est. Return
+23.65%
3 Year Est. Return
+66.72%
5 Year Est. Return
+71.27%
10 Year Est. Return
+298.51%
AUM
$4.09B
AUM Growth
+$147M
Cap. Flow
+$88.1M
Cap. Flow %
2.15%
Top 10 Hldgs %
16.38%
Holding
2,581
New
119
Increased
738
Reduced
625
Closed
122

Sector Composition

Rank Sector Weight
1 Technology 7.56%
2 Financials 4.69%
3 Healthcare 3.49%
4 Industrials 3.13%
5 Energy 2.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMT icon
1026
American Tower
AMT
$80.4B
$149K ﹤0.01%
851
-10
-1% -$1.82K
AON icon
1027
Aon
AON
$76B
$149K ﹤0.01%
423
JEMA icon
1028
JPMorgan ActiveBuilders Emerging Markets Equity ETF
JEMA
$1.66B
$149K ﹤0.01%
3,034
+78
+3% +$3.83K
VTR icon
1029
Ventas
VTR
$47.9B
$148K ﹤0.01%
1,913
+590
+45% +$44.5K
CRL icon
1030
Charles River Laboratories
CRL
$12.8B
$148K ﹤0.01%
741
+552
+292% +$100K
MTB icon
1031
M&T Bank
MTB
$36.2B
$147K ﹤0.01%
732
SRVR icon
1032
Pacer Data & Infrastructure Real Estate ETF
SRVR
$383M
$147K ﹤0.01%
5,135
+190
+4% +$5.73K
ADM icon
1033
Archer Daniels Midland
ADM
$36.9B
$146K ﹤0.01%
2,547
-469
-16% -$28K
PEG icon
1034
Public Service Enterprise Group
PEG
$37.7B
$146K ﹤0.01%
1,823
-130
-7% -$10.6K
BIO icon
1035
Bio-Rad Laboratories Class A
BIO
$9.42B
$146K ﹤0.01%
483
+467
+2,919% +$146K
SCI icon
1036
Service Corp International
SCI
$11.6B
$146K ﹤0.01%
1,867
+208
+13% +$16.6K
SMMU icon
1037
PIMCO Short Term Municipal Bond Active Exchange-Traded Fund
SMMU
$1.15B
$145K ﹤0.01%
2,880
+1,439
+100% +$72.6K
FLQS icon
1038
Franklin US Small Cap Multifactor Index ETF
FLQS
$53.1M
$145K ﹤0.01%
3,361
PJP icon
1039
Invesco Pharmaceuticals ETF
PJP
$479M
$145K ﹤0.01%
1,387
SMAY icon
1040
FT Vest US Small Cap Moderate Buffer ETF May
SMAY
$113M
$145K ﹤0.01%
5,580
LH icon
1041
Labcorp
LH
$25.9B
$145K ﹤0.01%
577
+347
+151% +$92.2K
AUGM
1042
FT Vest U.S. Equity Max Buffer ETF - August
AUGM
$31.8M
$143K ﹤0.01%
4,195
GSK icon
1043
GSK
GSK
$106B
$143K ﹤0.01%
2,908
+4
+0.1% +$187
IJS icon
1044
iShares S&P Small-Cap 600 Value ETF
IJS
$8.34B
$143K ﹤0.01%
1,254
-158
-11% -$17.7K
BLOK icon
1045
Amplify Blockchain Technology ETF
BLOK
$1.07B
$142K ﹤0.01%
2,500
-497
-17% -$32.1K
LOWV icon
1046
AB US Low Volatility Equity ETF
LOWV
$212M
$141K ﹤0.01%
1,800
IGIC icon
1047
International General Insurance
IGIC
$1.15B
$141K ﹤0.01%
5,618
-1,992
-26% -$46.7K
NCLH icon
1048
Norwegian Cruise Line
NCLH
$8.84B
$141K ﹤0.01%
6,303
VST icon
1049
Vistra
VST
$47.4B
$141K ﹤0.01%
871
+355
+69% +$64.7K
FISV
1050
Fiserv Inc
FISV
$27.9B
$140K ﹤0.01%
2,082
-59,784
-97% -$5M

Similar funds

Geneos Wealth Management's Q4 2025 Portfolio in Review

As of Q4 2025, Geneos Wealth Management held 2,581 positions worth $4.09B, up 3.7% from $3.94B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Geneos Wealth Management's Q4 2025 filing shows 119 new, 738 increased, 625 reduced and 122 closed positions. Its largest new stake was Vanguard S&P Small-Cap 600 ETF: 23,572 shares worth $2.62M. The largest sale was Norfolk Southern, an estimated $15M.

By sector, the portfolio is most concentrated in Technology at 7.6% of assets, down from 8.4% a quarter earlier, followed by Financials and Healthcare.

  • Geneos Wealth Management's largest Q4 2025 buy was Vanguard S&P Small-Cap 600 ETF: 23,572 shares worth $2.62M.
  • Geneos Wealth Management added most to Vanguard S&P 500 ETF in Q4 2025, an estimated $13.2M increase.
  • Geneos Wealth Management's biggest Q4 2025 reduction was Norfolk Southern, cutting an estimated $15M.
  • Geneos Wealth Management fully exited Cambria Global Value ETF in Q4 2025, selling an estimated $1.95M.
  • Geneos Wealth Management's ten largest holdings make up 16% of its $4.09B portfolio in Q4 2025.
  • Geneos Wealth Management opened 119 new positions and closed 122 in Q4 2025.
  • Geneos Wealth Management's portfolio value rose 3.7% quarter-over-quarter to $4.09B.

Based on Geneos Wealth Management's 13F filing for Q4 2025, filed 28 Jan 2026.